Oxoplatin-Based Pt(IV) Lipoate Complexes and Their Biological Activity

Area of Science:

• Inorganic Chemistry
• Medicinal Chemistry
• Cancer Biology

Background:

• Alpha-lipoic acid possesses anti-inflammatory and antioxidant properties.
• Platinum(IV) complexes are investigated as prodrugs for cancer therapy.
• Alpha-lipoic acid is a potential ligand for developing novel platinum-based anticancer agents.

Purpose of the Study:

• To synthesize and characterize new platinum(IV) lipoate complexes.
• To evaluate the anticancer activity of these Pt(IV) complexes.
• To investigate the mechanism of action, including reactive oxygen species (ROS) generation and DNA interaction.

Main Methods:

• Synthesis of three Pt(IV) lipoate complexes.
• Characterization using NMR spectroscopy (¹H, ¹³C, ¹⁹⁵Pt), mass spectrometry, and elemental analysis.
• In vitro evaluation of anticancer activity and ROS production in cell lines.

Main Results:

• Two Pt(IV) complexes with one axial lipoate ligand showed significant anticancer activity.
• Both active complexes induced reactive oxygen species (ROS) production in cancer cells.
• The monosubstituted complex was reduced by ascorbic acid and formed adducts with 9-methylguanine (9MeG), suggesting DNA crosslinking potential.

Conclusions:

• Pt(IV) lipoate complexes represent a promising class of anticancer prodrugs.
• The observed anticancer activity is linked to ROS generation and potential DNA crosslinking.
• Further development of these complexes, particularly the monosubstituted variant, warrants investigation for cancer treatment.